Skip to content
2000
Volume 3, Issue 2
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Monoamine oxidase (MAO) inhibitors were developed as antidepressants but many drugs, including the novel oxazolidinone antibacterial agents, share similar molecular properties and have MAO inhibitory activity. Factors important for binding antidepressants and modifications to decrease binding of oxazolidinones to avoid undesirable vascular effects are discussed.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557033405287
2003-03-01
2025-10-01
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557033405287
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test